You are here

molnupiravir

Merck asks EMA to reevaluate rejected Covid-19 antiviral

Merck asks EMA to reevaluate rejected Covid-19 antiviral

Endpoints

Flag link:

Merck Covid antiviral pill did not cut hospitalization risk, study finds

Merck Covid antiviral pill did not cut hospitalization risk, study finds

Financial Times

Flag link:

US sees spike in Paxlovid usage as Merck's molnupiravir and AstraZeneca's Evusheld are slower off the shelf

US sees spike in Paxlovid usage as Merck's molnupiravir and AstraZeneca's Evusheld are slower off the shelf

Endpoints

Flag link:

ICER says Pfizer's Paxlovid, Merck's molnupiravir both cost effective, but their benefits are far from equal

ICER says Pfizer's Paxlovid, Merck's molnupiravir both cost effective, but their benefits are far from equal

Fierce Pharma

Ridgeback Biotherapeutics

Flag link:

New Studies Support Benefit of Merck's Molnupiravir

New Studies Support Benefit of Merck's Molnupiravir

BioSpace

Ridgeback Biotherapeutics

clinical trials

Flag link:

Merck antiviral used more than expected, data shows

Merck antiviral used more than expected, data shows

Beckers Hospital Review

Flag link:

Merck’s Anti-Covid Pill Shows Better Effectiveness In Indian Study

Merck’s Anti-Covid Pill Shows Better Effectiveness In Indian Study

Forbes

Ridgeback Biotherapeutics

Flag link:

FDA updates Merck's Covid-19 pill EUA and reaffirms it should only be used as a last resort

FDA updates Merck's Covid-19 pill EUA and reaffirms it should only be used as a last resort

Endpoints

Flag link:

Will a New FDA-Approved COVID Pill Propel This Healthcare Company's Stock?

Will a New FDA-Approved COVID Pill Propel This Healthcare Company's Stock?

Motley Fool

Flag link:

27 drugmakers to provide generic COVID drug to low-income countries

27 drugmakers to provide generic COVID drug to low-income countries

Pharmaforum

Flag link:

Dr Reddy's to launch generic COVID-19 Merck drug at about 50 cents a pill

Dr Reddy's to launch generic COVID-19 Merck drug at about 50 cents a pill

Reuters

Flag link:

France Rejects Merck's COVID-19 Pill: How Bad Is the News?

France Rejects Merck's COVID-19 Pill: How Bad Is the News?

Motley Fool

Flag link:

FDA authorizes Merck’s Covid-19 pill, but stresses its use should be limited

FDA authorizes Merck’s Covid-19 pill, but stresses its use should be limited

Stat

Flag link:

Merck’s Covid Pill Might Pose Risks for Pregnant Women

Merck’s Covid Pill Might Pose Risks for Pregnant Women

NY Times, NY

Flag link:

Why an FDA Panel Had Concerns About Merck's COVID-19 Pill

Why an FDA Panel Had Concerns About Merck's COVID-19 Pill

Motley Fool

Flag link:

FDA panel narrowly recommends authorization of first antiviral pill to treat Covid-19

FDA panel narrowly recommends authorization of first antiviral pill to treat Covid-19

Stat

Ridgeback Biotherapeutics

Flag link:

New Merck study results raise questions about its COVID-19 pill

New Merck study results raise questions about its COVID-19 pill

BioPharma Dive

Flag link:

Covid antivirals could be pandemic game-changers. But Americans might struggle to access them

Covid antivirals could be pandemic game-changers. But Americans might struggle to access them

Stat

Flag link:

Will Pfizer's COVID Pill Crush the Hopes of Merck Investors?

Will Pfizer's COVID Pill Crush the Hopes of Merck Investors?

Motley Fool

Flag link:

8 lingering questions about the new Covid pills from Merck and Pfizer

8 lingering questions about the new Covid pills from Merck and Pfizer

Stat

Flag link:

Pages